Win Medicare launches
hepatonorm analyzer for detecting liver diseases
Delhi Based win Medicare (P)
Ltd has introduced Hepatonorm Analyzer, a novel product to detect Hepatic
Encephalopathy - a disease that occur due to acute liver diseases, such as liver
cirrhosis in India.
Hepatonorm Analyzer is used
to conduct "critical flicker frequency test", and is a device having a
small light point, which is flickering with such a high frequency that it
appears as a continuous light.
The frequency is decreased
gradually until the patient notices the flickering, and that frequency is noted.
In the presence of HE, the flickering cannot be appreciated till much later than
normal, stated a press release.
Win Medicare concentrates on
sourcing technologies, pharmaceutical and healthcare products as well as the
latest R&D from countries like Germany and Switzerland. The company had
recently established licensing arrangement with Merz Pharmaceuticals GmbH,
Germany for marketing their Hepatotherapeutic and other pharmaceutical products
including Contractubex, the release said.
Win Medicare has also
established licensing arrangement with IBSA, Switzerland for bolstering its
gynaecological products and Tillots Pharma AG Switzerland for its
gastroenterology range of products. Amongst the newer offerings is the emergency
contraceptive Norlevo (morning-after pill) from the original researcher, HRA
Pharma, France & HRT form Orion Pharma Finland.
(Ref : CHRONICLE PHARMABIZ
Dated December 23, 2004)
Hindustan Latex looks
into clinical services and pharma foray
After making condoms for
several decades, Hindustan Latex Ltd has drawn up a major diversification plan
which will see the company foraying into hospital products, clinical services
and even pharmaceutical sector.
The company is also looking
at the option of making an acquisition in the pharma sector in line with its
plan to make a foray into the sector. Sources said the PSU major has already
zeroed in on a company in the pharma sector for a possible acquisition, though
the plan still remains premature.
As part of the
diversification plan, Hindustan Latex will enter into alliances with some of the
leading international majors in areas such as hospital products and
hospital equipment. "We are currently preparing a road map for our growth
plans till 2010, which we will take to the board soon. This would mainly involve
foraying into newer area like hospital products and offering clinical services,
besides driving up our core condom business in a big way," HLL MD, M
Ayyappan told ET. The plan is based on the recommendations of consultancy major
Ernst and Young. The company has targeted a turnover of Rs 1,000 crore by 2010.
The PSU, which clocked a turnover of about Rs 205 crore. The proposed expansion
is estimated cost in excess of Rs 300 crore.
Hindustan Latex also plans to
set up a network of clinics, which would provide cheaper contraceptive inception
and related medical serivices. KPMG is learnt to be helping the PSU formulate
the business model for its clinical services foray. The company is already
running a pilot project in Andhra Pradesh. It plans to take the franchisee route
for setting up the clinics. Mr. Ayyappan said the company is currently in talks
with a Chinese company for possible tie-up in a new range of contraceptives.
He, however, refused to
divulge further details about it.
Sources said Hindustan Latex
is also in talks with a Japanese company for an alliance for its proposed foray
into hospital equipment segment. Though the name of the Japanese company could
not be known, the company proposes to launch the whole range of hospital
equipment including x-ray machines and scanner.
(Ref : Economic Times
Dated December 18, 2004)